
【个人简介】
郑灿灿,女,1992年8月出生,博士毕业于暨南大学生物化学与分子生物学专业,广州医科大学南山学者骨干人才,特聘教授,研究生导师,博士后合作导师。目前在广州医科大学附属第五医院前沿医学交叉研究中心工作。
【研究方向】
肿瘤发生发展的作用机制研究及靶向干预。
【科研项目】
1)国家自然科学基金-面上项目,2027.01.01-2030.12.31,49W, 在研,主持
2)广州医科大学高水平大学人才引进项目,2024/03-2024/03,300W, 在研,主持
3) 广东省自然科学基金-面上项目, 2025.01-2027.12,10万元,在研,主持
4) 广州市科学技术局-市校企联合资助项目,2025.01-2026.12,29万,在研,主持
5) 广州市科学技术局-基础与应用基础研究专题-青年博士“启航”项目,2025.01-2026.12,5万,在研,主持
6)国家自然科学基金-青年项目,2023.01.01-2025.12.31,30W,结题,主持
7)中国博士后面上基金项目,2022.03-2024.03,8W,结题,结题
【代表性论文及著作】
1) Can Can Zheng#, Qi Xiao Cui#, Jun Qi Li#, Jia Xi Chen, Li Wen He, Xin Zhang, Zhi Chao Liu, Ting Chen, Yuan Lyu, Chan Jin Liang, Shu Dong Ma, Min Ying Li, Xing Yuan Shi, Yong Xu Jia, Zhi Gang Li, Xin Jun Wang, Wen Wen Xu*, Bin Li* Phase separation of SMARCAL1 orchestrates epigenetic reprogramming and methionine metabolism to foster radioresistance and immunosuppression. Nature cell biology. 2026 ( IF=22.7,A1一区 )
2) Can-can Zheng; Xiaomei Yu; Yiyao Liang; Yidong Zhu; Yan He; Long Liao; Dingkang Wang; Yanming Yang; Xingfeng Yin; Ang Li; Qingyu He; Bin Li ; Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner, Acta Pharmaceutica Sinica B, 2022, 12(3): 1271-1287 ( IF=14.5,A1一区 )
3) Can‐Can Zheng#; Long Liao#; Ya‐Ping Liu#; Yan‐Ming Yang; Yan He; Guo‐Geng Zhang; Shu‐Jun Li; Ting Liu; Wen Wen Xu; Bin Li ; Blockade of Nuclear β ‐Catenin Signaling via Direct Targeting of RanBP3 with NU2058 Induces Cell Senescence to Suppress Colorectal Tumorigenesis, Advanced Science, 2022, 9(34): 2202528 ( IF=17.5,A1一区 )
4) Can-can Zheng#; Xiaomei Yu#; Taoyang Xu#; Zhichao Liu; Zhili Jiang; Jiaojiao Xu; Jing Yang; Guogeng Zhang; Yan He; Han Yang; Xingyuan Shi; Zhigang Li; Jinbao Liu; Wen Wen Xu ; KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer, Acta Pharmaceutica Sinica B, 2023, 13(10): 4217-4233 ( IF=14.5,A1一区 )
5) Yan He#; Can-Can Zheng#; Jing Yang#; Shu-Jun Li#; Tao-Yang Xu; Xian Wei; Wen-You Chen; Zhi-Li Jiang; Jiao-Jiao Xu; Guo-Geng Zhang; Chao Cheng; Kui-Sheng Chen; Xing-Yuan Shi; Da-Jiang Qin; Jin-Bao Liu; Bin Li ; Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance, Cell Discovery, 2023, 9(1): 74 (IF=38.1,A1一区 )
6) Chunmiao Deng; Yunfang Chen; Jiaojiao Xu; Chanjin Liang; Cui Shao; Shiqi Mei; Yongkang Xu; Yin Li; Cancan Zheng; Yichang Luo; Xingyuan Shi; Ganoderma lucidum polysaccharide ameliorates cancer cachexia with enhanced efficacy in aged group by reprogramming arginine metabolism to modulate Treg formation, Cancer Letters, 2026, 218247 (IF=11.29,A1一区 )
中国博士后面上基金项目,2022.03-2024.03,结题,主持